Sign In
Buy GTHP
$0.228
+0 (+0%)
At Close: Jun 03, 2026
Guided Therapeutics to Report First Quarter 2015 Results and Hold Conference Call; Provide Update on LuViva FDA Timing
08:05am, Wednesday, 29'th Apr 2015
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a point-of-care and painless testing platform that uses biophotonics for the early detection of dise
Guided Therapeutics to Report Fourth Quarter 2014 Results and Hold Conference Call; Provide Update on Business Activity
08:00am, Wednesday, 25'th Feb 2015
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, tod
Guided Therapeutics to Report Third Quarter 2014 Results and Hold Conference Call
08:01am, Thursday, 06'th Nov 2014
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced t
Guided Therapeutics to Report Second Quarter 2014 Results and Hold Conference Call
03:11pm, Thursday, 31'st Jul 2014
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, tod
Guided Therapeutics to Report First Quarter 2014 Results and Hold Conference Call
11:36am, Monday, 12'th May 2014
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced t
Guided Therapeutics to Report Fourth Quarter 2013 Results and Hold Conference Call
03:40pm, Wednesday, 05'th Mar 2014
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, tod
